Summary
Boston Scientific Corporation (BSX) reported its financial results for the quarterly period ended June 30, 2003. As an accelerated filer, the company has met its filing obligations for the preceding 12 months. The report provides an overview of the company's operational and financial status during this period. Investors should note that this filing covers a period over 20 years ago, and therefore, the information presented is historical and may not reflect the current state of the company. The report confirms that Boston Scientific Corporation has filed all required reports and has been subject to such filing requirements for the past 90 days, indicating compliance with SEC regulations. The company had 411,628,827 shares of common stock outstanding as of June 30, 2003. This filing is a routine quarterly report (Form 10-Q) and does not contain specific financial performance metrics like revenue or net income, as those details are typically found within the financial statements section of a 10-Q, which is not fully provided in the excerpt.
Key Highlights
- 1Boston Scientific Corporation (BSX) filed its Form 10-Q for the quarterly period ended June 30, 2003.
- 2The company is classified as an accelerated filer, indicating a history of timely SEC filings.
- 3BSX has met all reporting requirements for the preceding 12 months and the most recent 90-day period.
- 4As of June 30, 2003, the company had 411,628,827 shares of common stock outstanding.
- 5The filing confirms the company's legal and administrative structure (incorporated in Delaware, principal executive offices in Natick, Massachusetts).
- 6This is a historical filing from August 2003 and does not reflect current financial performance or strategic positioning.